We are live on ! Find out more
DMKJ

David M. Knott Jr Portfolio holdings

AUM $168M
1-Year Est. Return 60.36%
This Fund
S&P 500
This Quarter Est. Return
-12.56%
1 Year Est. Return
+60.36%
3 Year Est. Return
+143.93%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$212M
AUM Growth
-$64.6M
Cap. Flow
-$15M
Cap. Flow %
-7.08%
Top 10 Hldgs %
72.97%
Holding
103
New
14
Increased
10
Reduced
14
Closed
19

Top Buys

Rank Stock Value
1
RARE icon
Ultragenyx Pharmaceutical
RARE
+$2M
2
MYGN icon
Myriad Genetics
MYGN
+$1.92M
3
COGT icon
Cogent Biosciences
COGT
+$1.67M
4
REGN icon
Regeneron Pharmaceuticals
REGN
+$1.38M
5
TECX
Tectonic Therapeutic
TECX
+$1.3M

Top Sells

Rank Stock Value
1
CLMT icon
Calumet Specialty Products
CLMT
+$5.56M
2
VRNA
Verona Pharma
VRNA
+$4.26M
3
ICLO icon
Invesco AAA CLO Floating Rate Note ETF
ICLO
+$3.36M
4
JAAA icon
Janus Henderson AAA CLO ETF
JAAA
+$1.96M
5
VKTX icon
Viking Therapeutics
VKTX
+$1.57M

Sector Composition

Rank Sector Weight
1 Healthcare 33.25%
2 Materials 20.41%
3 Financials 19.12%
4 Communication Services 8.29%
5 Industrials 1.02%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BX icon
76
Blackstone
BX
$107B
$29.4K 0.01%
210
– –
OXY icon
77
Occidental Petroleum
OXY
$53.6B
$27.4K 0.01%
663
-586
-47% -$28.6K
TMO icon
78
Thermo Fisher Scientific
TMO
$214B
$22.4K 0.01%
45
– –
CRM icon
79
Salesforce
CRM
$149B
$20.7K 0.01%
77
– –
KD icon
80
Kyndryl
KD
$2.94B
$13.4K 0.01%
428
– –
STWD icon
81
Starwood Property Trust
STWD
$6.18B
$7.91K ﹤0.01%
400
– –
GEHC icon
82
GE HealthCare
GEHC
$29.2B
$4.04K ﹤0.01%
50
– –
WAB icon
83
Wabtec
WAB
$51.7B
$1.09K ﹤0.01%
6
– –
ADBE icon
84
Adobe
ADBE
$99B
– –
-35
Closed -$15.6K
BMRN icon
85
BioMarin Pharmaceuticals
BMRN
$12B
– –
-5,800
Closed -$381K
CMG icon
86
Chipotle Mexican Grill
CMG
$43B
– –
-500
Closed -$30.1K
DAKT icon
87
Daktronics
DAKT
$953M
– –
-7,803
Closed -$132K
EOLS icon
88
Evolus
EOLS
$410M
– –
-57,570
Closed -$636K
GE icon
89
GE Aerospace
GE
$377B
– –
-150
Closed -$25K
HD icon
90
Home Depot
HD
$343B
– –
-80
Closed -$31.1K
KVUE icon
91
Kenvue
KVUE
$37.9B
– –
-2,235
Closed -$47.7K
LIN icon
92
Linde
LIN
$236B
– –
-70
Closed -$29.3K
CYPH
93
Cypherpunk Technologies Inc
CYPH
$65.4M
– –
-23,626
Closed -$67.9K
MDT icon
94
Medtronic
MDT
$111B
– –
-8,000
Closed -$639K
ROIV icon
95
Roivant Sciences
ROIV
$24.3B
– –
-4,005
Closed -$47.4K
SSB icon
96
SouthState Bank Corp
SSB
$10.3B
– –
-534
Closed -$53.1K
VKTX icon
97
Viking Therapeutics
VKTX
$3.93B
– –
-39,036
Closed -$1.57M
VRTX icon
98
Vertex Pharmaceuticals
VRTX
$124B
– –
-2,000
Closed -$805K
XFOR icon
99
X4 Pharmaceuticals
XFOR
$371M
– –
-5,136
Closed -$113K
XOMA
100
DELISTED
Xoma
XOMA
– –
-19,722
Closed -$518K
1 2 3
4
5

Similar funds

DI
Disciplined Investors Waco, Texas $168M AUM 23.6% 1-Year Est. Return
WFS
Widmann Financial Services Bowie, Maryland $168M AUM 24.36% 1-Year Est. Return
CCG
Catalina Capital Group Torrance, California $168M AUM 16.69% 1-Year Est. Return
7CM
7G Capital Management New York $168M AUM 45.68% 1-Year Est. Return
MAG
Meadowbrook Advisors Group Bedminster, New Jersey $168M AUM
PFA
Presper Financial Architects Akron, Ohio $168M AUM 12.94% 1-Year Est. Return
CW
Code Waechter Tampa, Florida $168M AUM 15.56% 1-Year Est. Return
IWA
Integrity Wealth Advisors Ventura, California $168M AUM 18.33% 1-Year Est. Return

David M. Knott Jr's Q1 2025 Portfolio in Review

As of Q1 2025, David M. Knott Jr held 103 positions worth $212M, down 23% from $277M the previous quarter. Its ten largest holdings account for 73% of the portfolio.

David M. Knott Jr withdrew a net $15M in Q1 2025, closing 19 positions and reducing 14 holdings. Its most notable exit was Viking Therapeutics, an estimated $1.57M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 33% of assets, up from 26% a quarter earlier, followed by Materials and Financials.

Against the trend, David M. Knott Jr opened a new position in Ultragenyx Pharmaceutical worth $1.74M.

  • David M. Knott Jr's largest Q1 2025 buy was Ultragenyx Pharmaceutical: 48,000 shares worth $1.74M.
  • David M. Knott Jr added most to Protagonist Therapeutics in Q1 2025, an estimated $990K increase.
  • David M. Knott Jr's biggest Q1 2025 reduction was Calumet Specialty Products, cutting an estimated $5.56M.
  • David M. Knott Jr fully exited Viking Therapeutics in Q1 2025, selling an estimated $1.57M.
  • David M. Knott Jr's ten largest holdings make up 73% of its $212M portfolio in Q1 2025.
  • David M. Knott Jr opened 14 new positions and closed 19 in Q1 2025.
  • David M. Knott Jr's portfolio value fell 23% quarter-over-quarter to $212M.

Based on David M. Knott Jr's 13F filing for Q1 2025, filed 12 May 2025.